PT  - JOURNAL ARTICLE
AU  - Namsrai, Tergel
AU  - Desborough, Jane
AU  - Chalmers, Anita
AU  - Lowe, Christine
AU  - Cook, Matthew
AU  - Phillips, Christine
AU  - Parkinson, Anne
TI  - Diagnostic delay of Myositis: protocol for an integrated systematic review
AID  - 10.1101/2022.04.27.22274397
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.04.27.22274397
4099  - http://medrxiv.org/content/early/2022/04/28/2022.04.27.22274397.short
4100  - http://medrxiv.org/content/early/2022/04/28/2022.04.27.22274397.full
AB  - Idiopathic inflammatory myopathies (IIM) described as “inflammatory myositis”, are a heterogeneous group of rare muscular autoimmune diseases characterized by skeletal muscle inflammation. Its complex characteristics with lack of accurate diagnostic tests, unified classification system, and comprehensive widely used diagnostic criteria could lead to diagnostic delay. This study will review diagnostic delay in Myositis and provide an overview and clearer insight of patients’ experiences, causes and consequences of diagnostic delay in Myositis.Methods and analysis The literature source will be a systematic search of PubMed/Medline, Scopus, ProQuest, and sources of grey literature, conducted from database inception to 15th of December 2021 without restrictions on publication date. All study types (qualitative and quantitative) except review articles, examining diagnostic delay, incorrect diagnosis, missed diagnosis or slow diagnosis of all types of myositis in all ages will be included. Evidence of patients’ experiences associated with diagnostic delay will also be examined. Studies in languages other than English, German and Indonesian will be excluded. Outcomes will be diagnostic delay time, patients’ experiences, and causes and consequences associated with diagnostic delay in Myositis. Two review authors will independently screen the titles and abstracts of search results against the inclusion criteria. The Mixed Methods Appraisal Tool (MMAT) will be used to appraise selected studies. Two independent authors will extract data using a pre-piloted data extraction tool. If sufficient quantitative data is available, a meta-analysis will be conducted along with subgroup analysis including pooled diagnostic delay in each type of Myositis. Qualitative data will be analysed in line with meta-aggregation methods. If data is insufficient, a narrative synthesis will be conducted.Ethics and dissemination As a systematic review, ethical approval was not required. Findings of the study will be disseminated through publications in peer-reviewed journals, conferences, and symposia.PROSPERO Registration number CRD42022289830Strengths and limitations of this studyThe protocol was developed in accordance with Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols guidelines and the Cochrane Handbook for Systematic Reviews.Examination of both quantitative and qualitative literature will enable insight into the causes and consequences, and patients’ experiences associated with diagnostic delay of Myositis.In some case studies, it will be necessary to manually calculate diagnostic delay according to the date of symptom onset and the date of diagnosis.The primary limitation of this study is that it will not capture evidence that is not published, or from situations when an accurate diagnosis of Myositis is not made.The review will be limited to English, German, and Indonesian studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis review is part of the Missed opportunities in clinical practice: Tools to enhance healthcare providers awareness and diagnosis of rare diseases in Australia project funded by the Commonwealth represented by Department of Health Australia (Grant ID 4-G5ZN0T7).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors